Global Drug Abuse Testing Market 2014-2018

薬物乱用テストの世界市場:薬物検査キット、薬物検査装置

◆タイトル:Global Drug Abuse Testing Market 2014-2018
◆商品コード:IRTNTR4393
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2014年10月22日
◆ページ数:75
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥316,400見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、"薬物乱用テストの世界市場:薬物検査キット、薬物検査装置"について調査・分析し、エグゼクティブサマリー、市場概観、市場規模及び予測、技術別分析、主要地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析等の情報をお届けいたします。

About Drug Abuse Testing
Drugs are chemical substances, which are generally used in the diagnosis, treatment, and prevention of diseases. Drugs when used as medicines have positive effects on patients; however, some people use drugs for non-medical purposes, which leads to serious health problems. Drug abuse testing is a technical analysis of biological specimen to determine the drugs or combination of drugs consumed by a person. The biological specimens used for the test are saliva, urine, blood, hair, breath, and sweat. The two main technologies used to test drug abuse are immunoassay and chromatography. Drug abuse testing is widely used in diagnostics, criminal cases, and to screen sports athletes.

TechNavio’s analysts forecast the Global Drug Abuse Testing market to grow at a CAGR of 4.71 percent over the period 2013-2018.

[Covered in this Report]
This report covers the present scenario and the growth prospects of the Global Drug Abuse Testing market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from sales of drug abuse testing solutions, which includes drug abuse testing kits and systems. The technologies primarily considered in the report are immunoassay and chromatography.

TechNavio’s report, the Global Drug Abuse Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC and EMEA regions; it also covers the Global Drug Abuse Testing market landscape and its growth prospects in the coming years. The report includes a discussion on the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• Bio-Rad Laboratories
• Danaher
• F. Hoffmann-La Roche
• Siemens
• Thermo Fisher Scientific

[Other Prominent Vendors]
• Abbott Laboratories
• Agilent Technologies
• Alere
• Biomedical Diagnostics
• Branan Medical
• OraSure Technologies
• PerkinElmer
• Psychemedics
• Quest Diagnostic
• Randox Laboratories
• Sigma-Aldrich
• Sonic Healthcare
• Waters

[Market Driver]
• Rise in Consumption of Illicit Drugs
• For a full, detailed list, view our report

[Market Challenge]
• Inability to Detect Low-dose Designer Drugs
• For a full, detailed list, view our report

[Market Trend]
• Increase in Number of Collaborations and M&A
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Overview
06.1 Epidemiology
06.2 Commonly Abused Drugs:
06.3 Harm Caused by Drugs Abuse
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Technique
09. Geographical Segmentation
09.1 Drugs Abuse Testing Market in Americas
09.1.1 Market Size and Forecast
09.2 Drugs Abuse Testing Market in EMEA Region
09.2.1 Market Size and Forecast
09.3 Drugs Abuse Testing Market in APAC Region
09.3.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Vendor Analysis 2013
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Bio-Rad
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation
18.1.4 Business Strategy
18.1.5 Business Segmentation by Revenue
18.1.6 Business Segmentation by Revenue 2011 and 2012
18.1.7 Geographical Segmentation by Revenue 2012
18.1.8 Key Developments
18.1.9 SWOT Analysis
18.2 Danaher
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation
18.2.4 Revenue by Business Segmentation
18.2.5 Revenue Comparison 2012 and 2013
18.2.6 Segmentation by Geography
18.2.7 Business Strategy
18.2.8 Key Information
18.2.9 SWOT Analysis
18.3 F. Hoffmann-La Roche
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2013
18.3.4 Business Segmentation by Revenue 2012 and 2013
18.3.5 Geographical Segmentation by Revenue 2013
18.3.6 Business Strategy
18.3.7 Recent Developments
18.3.8 SWOT Analysis
18.4 Siemens
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation 2013
18.4.4 Revenue by Business Segmentation 2013
18.4.5 Revenue Comparison by Business Segmentation 2012 and 2013
18.4.6 Geographical Segmentation by Revenue 2013
18.4.7 Business Strategy
18.4.8 Recent Developments
18.4.9 SWOT Analysis
18.5 Thermo Fisher Scientific
18.5.1 Key Facts
18.5.2 Business Overview
18.5.3 Business Segmentation
18.5.4 Business Segmentation by Revenue
18.5.5 Product Segmentation by Revenue
18.5.6 Geographical Segmentation by Revenue 2013
18.5.7 Business Strategy
18.5.8 Key Information
18.5.9 SWOT Analysis
19. Other Reports in this Series

[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Harm Caused by Drugs Abuse
Exhibit 3: Global Drugs Abuse Testing Market 2013-2018 (US$ million)
Exhibit 4: Global Drugs Abuse Testing Market Segmentation by Technology
Exhibit 5: Global Drugs Abuse Testing Market Segmentation by Geography 2013
Exhibit 6: Drugs Abuse Testing Market in Americas 2013-2018 (US$ million)
Exhibit 7: Drugs Abuse Testing Market in EMEA Region 2013-2018 (US$ million)
Exhibit 8: Drugs Abuse Testing Market in APAC Region 2013-2018 (US$ million)
Exhibit 9: Bio-Rad: Business Segmentation
Exhibit 10: Bio-Rad: Business Segmentation by Revenue 2012
Exhibit 11: Bio-Rad: Business Segmentation by Revenue 2011 and 2012 (US$ million)
Exhibit 12: Bio-Rad: Geographical Segmentation by Revenue 2012
Exhibit 13: Danaher: Business Segmentation
Exhibit 14: Danaher: Business Segmentation 2013
Exhibit 15: Danaher: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 16: Danaher: Revenue by Geographical Segmentation 2013
Exhibit 17: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
Exhibit 18: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 19: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Pharmaceuticals)
Exhibit 20: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Diagnostics)
Exhibit 21: Siemens: Business Segmentation 2013
Exhibit 22: Siemens: Revenue by Business Segmentation 2013
Exhibit 23: Siemens: Revenue by Business Segmentation 2012 and 2013 (US$ billion)
Exhibit 24: Siemens: Geographical Segmentation by Revenue 2013
Exhibit 25: Thermo Fisher: Business Segmentation
Exhibit 26: Thermo Fisher: Business Segmentation by Revenue 2013
Exhibit 27: Thermo Fisher: Product Segmentation by Revenue 2013
Exhibit 28: Thermo Fisher: Geographical Segmentation by Revenue 2013



【掲載企業】

Bio-Rad Laboratories,Danaher,F. Hoffmann-La Roche,Siemens,Thermo Fisher Scientific ,Abbott Laboratories,Agilent Technologies,Alere,Biomedical Diagnostics,Branan Medical,OraSure Technologies,PerkinElmer,Psychemedics,Quest Diagnostic,Randox Laboratories,Sigma-Aldrich,Sonic Healthcare,Waters

【資料のキーワード】

薬物乱用、薬物検査キット、薬物検査装置、免疫測定、クロマトグラフィ

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[薬物乱用テストの世界市場:薬物検査キット、薬物検査装置]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆